Literature DB >> 11698691

Melatonin receptor signaling: finding the path through the dark.

M I Masana1, M L Dubocovich.   

Abstract

Melatonin, dubbed "the hormone of darkness," is involved in relaying photoperiodic information to the organism. Not only is melatonin involved in the regulation of circadian rhythms and sleep, but it also has roles in visual, cerebrovascular, reproductive, neuroendocrine, and neuroimmunological functions. Melatonin mediates its effects through G protein-coupled receptors: MT(1), MT(2), and, possibly, MT(3). Pharmacological agents have been instrumental in identifying these receptor types. Masana and Dubocovich discuss how the level of receptor expression may alter their efficacy, so that caution is necessary when extrapolating the pharmacological properties of ligands defined on recombinant systems to the receptors in the organism. With these cautions in mind, they describe the various signaling pathways and physiological roles ascribed to the three melatonin receptor types.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698691     DOI: 10.1126/stke.2001.107.pe39

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  40 in total

Review 1.  Expression and putative functions of melatonin receptors in malignant cells and tissues.

Authors:  Cem Ekmekcioglu
Journal:  Wien Med Wochenschr       Date:  2014-07-15

2.  Melatonin MT₁ and MT₂ receptors display different molecular pharmacologies only in the G-protein coupled state.

Authors:  Céline Legros; Séverine Devavry; Sarah Caignard; Clémence Tessier; Philippe Delagrange; Christine Ouvry; Jean A Boutin; Olivier Nosjean
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

3.  Melatonin sensitizes human myometrial cells to oxytocin in a protein kinase C alpha/extracellular-signal regulated kinase-dependent manner.

Authors:  James T Sharkey; Casey Cable; James Olcese
Journal:  J Clin Endocrinol Metab       Date:  2010-04-09       Impact factor: 5.958

4.  Circadian 5-HT production regulated by adrenergic signaling.

Authors:  Xing Sun; Jie Deng; Tiecheng Liu; Jimo Borjigin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

Review 5.  Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.

Authors:  Md Farhad Hossain; Md Sahab Uddin; G M Sala Uddin; Dewan Md Sumsuzzman; Md Siddiqul Islam; George E Barreto; Bijo Mathew; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2019-06-17       Impact factor: 5.590

Review 6.  Functional MT1 and MT2 melatonin receptors in mammals.

Authors:  Margarita L Dubocovich; Magdalena Markowska
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

7.  Characterizing Sleep in Adolescents and Adults with Autism Spectrum Disorders.

Authors:  S E Goldman; M L Alder; H J Burgess; B A Corbett; R Hundley; D Wofford; D B Fawkes; L Wang; M L Laudenslager; B A Malow
Journal:  J Autism Dev Disord       Date:  2017-06

8.  Effect of melatonin on phagocytic activity and intracellular free calcium concentration in testicular macrophages from normal and streptozotocin-induced diabetic rats.

Authors:  Joanna Pawlak; Jaipaul Singh; Robert W Lea; Krystyna Skwarlo-Sonta
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

Review 9.  Physiological and metabolic functions of melatonin.

Authors:  J Barrenetxe; P Delagrange; J A Martínez
Journal:  J Physiol Biochem       Date:  2004-03       Impact factor: 4.158

10.  Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay.

Authors:  Olivia J Veatch; Julie S Pendergast; Melissa J Allen; Roberta M Leu; Carl Hirschie Johnson; Sarah H Elsea; Beth A Malow
Journal:  J Autism Dev Disord       Date:  2015-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.